Varenicline improves motor and cognitive symptoms in early Huntington’s disease
Ailsa L McGregor,1,2 Jo Dysart,3 Malcolm D Tingle,4 Bruce R Russell,1,2 Rob R Kydd,5 Gregory Finucane2 1New Zealand’s National School of Pharmacy, Division of Health Sciences, University of Otago, Dunedin, New Zealand; 2Centre for Brain Research, University of Auckland, 3Liaison Psychiatr...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/d434258d59e242baa2cc61b808c0df70 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:d434258d59e242baa2cc61b808c0df70 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:d434258d59e242baa2cc61b808c0df702021-12-02T04:39:25ZVarenicline improves motor and cognitive symptoms in early Huntington’s disease1178-2021https://doaj.org/article/d434258d59e242baa2cc61b808c0df702016-09-01T00:00:00Zhttps://www.dovepress.com/varenicline-improves-motor-and-cognitive-symptoms-in-early-huntingtonr-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Ailsa L McGregor,1,2 Jo Dysart,3 Malcolm D Tingle,4 Bruce R Russell,1,2 Rob R Kydd,5 Gregory Finucane2 1New Zealand’s National School of Pharmacy, Division of Health Sciences, University of Otago, Dunedin, New Zealand; 2Centre for Brain Research, University of Auckland, 3Liaison Psychiatry, Auckland City Hospital, 4Department of Pharmacology and Clinical Pharmacology, 5Department of Psychological Medicine, University of Auckland, Auckland, New Zealand Abstract: The aim of this study was to describe the effects of varenicline, a smoking cessation aid that acts as a nicotinic agonist, on cognitive function in patients with early clinical Huntington’s disease (HD) who were current smokers. Three gene-positive patients transitioning to symptomatic HD were evaluated using the Unified Huntington’s Disease Rating Scale part I and III (motor and behavioral subscales) at baseline and after 4 weeks of treatment. Cognitive function was assessed using a touch screen computer-based neurocognitive test battery (IntegNeuro®). Varenicline (1 mg twice daily) significantly improved performance in executive function and emotional recognition tasks. Our case reports describe no clinically significant adverse effects and suggest that varenicline improves aspects of cognitive function in patients with early HD. A randomized controlled study is now underway. Keywords: varenicline, Huntington’s disease, cognitive symptomsMcGregor ALDysart JTingle MDRussell BRKydd RRFinucane GDove Medical Pressarticlehuntington's diseasecognitive impairmentvareniclineNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 12, Pp 2381-2386 (2016) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
huntington's disease cognitive impairment varenicline Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
huntington's disease cognitive impairment varenicline Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 McGregor AL Dysart J Tingle MD Russell BR Kydd RR Finucane G Varenicline improves motor and cognitive symptoms in early Huntington’s disease |
| description |
Ailsa L McGregor,1,2 Jo Dysart,3 Malcolm D Tingle,4 Bruce R Russell,1,2 Rob R Kydd,5 Gregory Finucane2 1New Zealand’s National School of Pharmacy, Division of Health Sciences, University of Otago, Dunedin, New Zealand; 2Centre for Brain Research, University of Auckland, 3Liaison Psychiatry, Auckland City Hospital, 4Department of Pharmacology and Clinical Pharmacology, 5Department of Psychological Medicine, University of Auckland, Auckland, New Zealand Abstract: The aim of this study was to describe the effects of varenicline, a smoking cessation aid that acts as a nicotinic agonist, on cognitive function in patients with early clinical Huntington’s disease (HD) who were current smokers. Three gene-positive patients transitioning to symptomatic HD were evaluated using the Unified Huntington’s Disease Rating Scale part I and III (motor and behavioral subscales) at baseline and after 4 weeks of treatment. Cognitive function was assessed using a touch screen computer-based neurocognitive test battery (IntegNeuro®). Varenicline (1 mg twice daily) significantly improved performance in executive function and emotional recognition tasks. Our case reports describe no clinically significant adverse effects and suggest that varenicline improves aspects of cognitive function in patients with early HD. A randomized controlled study is now underway. Keywords: varenicline, Huntington’s disease, cognitive symptoms |
| format |
article |
| author |
McGregor AL Dysart J Tingle MD Russell BR Kydd RR Finucane G |
| author_facet |
McGregor AL Dysart J Tingle MD Russell BR Kydd RR Finucane G |
| author_sort |
McGregor AL |
| title |
Varenicline improves motor and cognitive symptoms in early Huntington’s disease |
| title_short |
Varenicline improves motor and cognitive symptoms in early Huntington’s disease |
| title_full |
Varenicline improves motor and cognitive symptoms in early Huntington’s disease |
| title_fullStr |
Varenicline improves motor and cognitive symptoms in early Huntington’s disease |
| title_full_unstemmed |
Varenicline improves motor and cognitive symptoms in early Huntington’s disease |
| title_sort |
varenicline improves motor and cognitive symptoms in early huntington’s disease |
| publisher |
Dove Medical Press |
| publishDate |
2016 |
| url |
https://doaj.org/article/d434258d59e242baa2cc61b808c0df70 |
| work_keys_str_mv |
AT mcgregoral vareniclineimprovesmotorandcognitivesymptomsinearlyhuntingtonrsquosdisease AT dysartj vareniclineimprovesmotorandcognitivesymptomsinearlyhuntingtonrsquosdisease AT tinglemd vareniclineimprovesmotorandcognitivesymptomsinearlyhuntingtonrsquosdisease AT russellbr vareniclineimprovesmotorandcognitivesymptomsinearlyhuntingtonrsquosdisease AT kyddrr vareniclineimprovesmotorandcognitivesymptomsinearlyhuntingtonrsquosdisease AT finucaneg vareniclineimprovesmotorandcognitivesymptomsinearlyhuntingtonrsquosdisease |
| _version_ |
1718401153609236480 |